Matt Klebanoff
@mattklebanoff.bsky.social
doctor, fellow at Penn NCSP | rx access/affordability & health care-related administrative burdens
So much bad news today, including for CMMI's new prescription drug models. Hopefully these models survive or get revived in some form (maybe try renaming it the Trump $2 Drug List?).
Trump’s initial orders reverse Biden on health care costs, protections from discrimination
Trump's executive orders took aim at Biden's priorities, from drug pricing to gender discrimination.
www.statnews.com
January 21, 2025 at 3:10 PM
So much bad news today, including for CMMI's new prescription drug models. Hopefully these models survive or get revived in some form (maybe try renaming it the Trump $2 Drug List?).
Reposted by Matt Klebanoff
December 6, 2024 at 4:58 PM